Search Within

Wenhuo Hu

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (16)
  2. Meeting Abstract (11)
  3. Editorial (1)
Groups
  1. Department of Medicine (28)
  2. GSK Faculty (28)
  3. Human Oncology and Pathogenesis Program (28)
  4. Sloan Kettering Institute Postdocs (28)
  5. Solid Tumor Oncology Division (25)
  6. Department of Pathology and Laboratory Medicine (21)

More Groups

People
  1. David Solit (18)
  2. Hikmat Al-Ahmadie (15)
  3. Gopakumar Iyer (14)
  4. Eugene Pietzak (12)
  5. Jonathan Rosenberg (10)
  6. Sizhi Gao (10)

More People

Years
  1. 2025 (2)
  2. 2022 (5)
  3. 2021 (3)
  4. 2020 (5)
  5. 2019 (3)
  6. 2018 (2)

More Years

Publications
  1. Cancer Research (5)
  2. Journal of Clinical Oncology (3)
  3. Blood (2)
  4. European Urology (2)
  5. Nature Communications (2)
  6. Science Translational Medicine (2)

More Publications

Publishers
  1. American Association for Cancer Research (8)
  2. Nature Publishing Group (4)
  3. American Society of Clinical Oncology (3)
  4. American Association for the Advancement of Science (2)
  5. American Society of Hematology (2)
  6. Cell Press (2)

More Publishers

Results (28)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular heterogeneity and immune infiltration drive clinical outcomes in upper tract urothelial carcinoma
    Journal Article

    Kim, K.; Alam, S. M.; Kuo, F.; Chen, Z.; Yip, W.; Katims, A. B.; Chu, C.; Lenis, A. T.; Hu, W.; Gokturk Ozcan, G.; more...
    European Urology (2025)

    Fulltext@MSK | Save
  • Loss of KMT2C or KMT2D primes urothelium for tumorigenesis and redistributes KMT2A-menin to bivalent promoters
    Journal Article

    Wang, N.; Pachai, M. R.; Li, D.; Lee, C. J.; Warda, S.; Khudoynazarova, M. N.; Cho, W. H.; Xie, G.; Shah, S. R.; Yao, L.; more...
    Nature Genetics (2025)

    Fulltext@MSK | Save
  • Genomic heterogeneity as a barrier to precision oncology in urothelial cancer
    Meeting Abstract

    Chen, Z.; Clinton, T. N.; Park, S.; Lenis, A. T.; Donoghue, M.; Rosenberg, J. E.; Dean, B. F.; Teo, M. Y.; Bochner, B. H.; Ostrovnaya, I.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Inactivation mutations of KMT2C/D license a molecular "field effect" and prime the urothelium for tumorigenesis
    Meeting Abstract

    Wang, N.; Pachai, M. R.; Li, D.; Lee, C.; Warda, S.; Xie, G.; Qian, C.; Wong, W. P. E.; Yan, J.; Hu, W.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Genomic heterogeneity as a barrier to precision oncology in urothelial cancer
    Journal Article

    Clinton, T. N.; Chen, Z.; Wise, H.; Lenis, A. T.; Chavan, S.; Donoghue, M. T. A.; Almassi, N.; Chu, C. E.; Dason, S.; Rao, P.; more...
    Cell Reports (2022)

    Fulltext@MSK | Save
  • FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation
    Journal Article

    Warrick, J. I.; Hu, W.; Yamashita, H.; Walter, V.; Shuman, L.; Craig, J. M.; Gellert, L. L.; Castro, M. A. A.; Robertson, A. G.; Kuo, F.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Upper tract urothelial carcinoma transcriptome profiling and immune microenvironment characterization
    Meeting Abstract

    Yip, W.; Kim, K.; Kuo, F.; Lenis, A. T.; Chen, J. F.; Hu, W.; Clinton, T. N.; Chu, C. E.; Almassi, N.; Tracey, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • TNFR2/14-3-3ε signaling complex instructs macrophage plasticity in inflammation and autoimmunity
    Journal Article

    Fu, W.; Hu, W.; Yi, Y. S.; Hettinghouse, A.; Sun, G.; Bi, Y.; He, W.; Zhang, L.; Gao, G.; Liu, J.; more...
    Journal of Clinical Investigation (2021)

    Fulltext@MSK | Save
  • Genomic characterization of bladder cancer with variant histology
    Meeting Abstract

    Lenis, A. T.; Clinton, T. N.; Hu, W.; Almassi, N.; Reisz, P.; Truong, H.; Thomas, J.; Nagar, K.; Goh, A.; Cha, E. K.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • AKT1 E17K inhibits cancer cell migration by abrogating β-catenin signaling
    Journal Article

    Gao, S. P.; Kiliti, A. J.; Zhang, K.; Vasani, N.; Mao, N.; Jordan, E.; Wise, H. C.; Shrestha Bhattarai, T.; Hu, W.; Dorso, M.; more...
    Molecular Cancer Research (2021)

    Fulltext@MSK | Save